Allink Biotherapeutics, Inc. has raised $47 million in a Series A funding round led by Legend Capital and Meituan Long-Z Investment to advance its clinical programs for oncology and immunology.
Amount Raised
$47 Million
Round Type
Series A
ShanghaiBiotechnologyHealth CareInvestors
Description
Allink Biotherapeutics, Inc. announced the successful closing of additional Series A funding rounds, raising $47 million. The funding will support the global clinical development of its two lead programs, ALK201 and ALK202. ALK201 targets FGFR2b and shows encouraging efficacy in various tumor types
Quick answer
Allink Biotherapeutics raised $47 Million in a Series A round, dated December 16, 2025. Investors: 5Y Capital, Lanchi Ventures, Yuanbio Venture Capital, Lapam Capital, Runzhang Venture Capital, Legend Capital and Meituan Long Z Investment. Allink Biotherapeutics is based in Shanghai, Shanghai, China.
- How much did Allink Biotherapeutics raise?
- Allink Biotherapeutics raised $47 Million in a Series A round on December 16, 2025.
- Who invested in Allink Biotherapeutics?
- 5Y Capital, Lanchi Ventures, Yuanbio Venture Capital, Lapam Capital, Runzhang Venture Capital, Legend Capital and Meituan Long Z Investment are named as investors in this round.
- What does Allink Biotherapeutics do?
- AllinkBio is a clinical stage biotechnology company leveraging its innovative proprietary platforms in bispecific antibodies and ADCs to develop a diverse pipeline of First-in-Class (FIC) and Best-in-Class (BIC)..
- Where is Allink Biotherapeutics based and how big is it?
- Allink Biotherapeutics is based in Shanghai, Shanghai, China.
- Who are the decision-makers at Allink Biotherapeutics?
- Fundz holds 1 contact at Allink Biotherapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who to call at Allink Biotherapeutics, and when
A new round usually means Allink Biotherapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Allink Biotherapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Allink Biotherapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Allink Biotherapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Allink Biotherapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansAllink Biotherapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.